Hypoglycemia: Clinical Trials

34 trials for Hypoglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 completed. 34 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 434Completed 34

Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2
Phase 4CompletedFundación para la Investigación del Hospital Clínico de Valencia922025-05-262026-09-04
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
Empagliflozin 25 MG, Placebo - Dumping Syndrome, Hypoglycemia, Reactive
Phase 4CompletedInsel Gruppe AG, University Hospital Bern222021-12-012023-03-14
Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
Glucagon, Closed-loop system - Type 1 Diabetes, Hypoglycemia
Phase 4CompletedSteno Diabetes Center Copenhagen132019-07-162022-08-18
Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia
Ciprofloxacin 400 MG/200 ML Intravenous Solution, Levofloxacin 750 MG - QTc Prolongation, Hyperglycemia, Hypoglycemia
Phase 4CompletedBeni-Suef University2002018-06-012020-07-02
Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone
Hydrocortisone, Prednisolone - Corticotropin Deficiency, Fasting
Phase 4CompletedUniversity Tunis El Manar532018-05-172019-04-29
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study
Technosphere insulin - Diabetes Mellitus, Type 1
Phase 4CompletedUniversity of Colorado, Denver602017-09-302022-02-22
Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Metformin and Glimepiride (Low Dosage), Metformin and Vildagliptin (Low Dosage), Metformin and Insulin Glargine U100 (Low Dosage) - Diabetes Mellitus, Type 2
Phase 4CompletedUniversity of Jordan6872017-02-142020-02-11
The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes
Alcohol, Placebo - Hypoglycemia, Diabetes Mellitus, Type 1
Phase 4CompletedHvidovre University Hospital122016-08-012017-07-24
Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
Insulin, insulin - Diabete Type 2, Hyperglycemia
Phase 4CompletedHospital Universitario Clinica San Rafael1162016-01-012023-03-03
Treatment of Hypoglycemia Following Gastric Bypass Surgery
Glucobay (acarbose), Januvia (sitagliptin), Verapamil HEXAL (verapamil) - Hypoglycemia, Obesity
Phase 4CompletedZealand University Hospital112015-10-012018-03-07
Glucagon Efficiency After High and Low Carbohydrate Diet
High carbohydrate intake, Low carbohydrate intake - Type 1 Diabetes, Hypoglycemia
Phase 4CompletedHvidovre University Hospital102015-10-012016-08-16
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
Insulin glargine, Insulin aspart, Supplemental insulin aspart - Diabetes Mellitus, Type 2
Phase 4CompletedEmory University2262015-10-012023-09-28
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Exenatide, Glargine, Rapid-acting insulin analogs - Type 2 Diabetes
Phase 4CompletedEmory University1502015-09-012019-06-20
Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Insulin aspart/glargine, Insulin aspart/degludec - Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia
Phase 4CompletedNordsjaellands Hospital1492015-01-012019-06-27
Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
vildagliptin and metformin (combination), glimepiride, Metformin - Type 2 Diabetes, Hypoglycemia
Phase 4CompletedNovartis Pharmaceuticals402014-01-032017-07-11
Study on Lixisenatide and Counterregulation to Hypoglycemia
Lixisenatide - Type 2 Diabetes
Phase 4CompletedLund University182013-12-012015-12-15
Hypoglycemia and Autonomic Nervous System Function-B
Spironolactone, Placebo, Hypoglycemic Hyperinsulinemic Clamp - Hypoglycemia, Healthy
Phase 4CompletedBrigham and Women's Hospital282013-07-172026-01-02
The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery
glucomannan - Hypoglycemia
Phase 4CompletedBassett Healthcare102013-05-012017-03-13
Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
Vildagliptin, Gliclazide, Metformin - Type 2 Diabetes Mellitus
Phase 4CompletedNovartis Pharmaceuticals5572013-01-012013-10-17
Liraglutide in Type 1 Diabetes
Liraglutide, Placebo - Diabetes Mellitus, Type 1, Overweight
Phase 4CompletedSteno Diabetes Center Copenhagen1002012-06-012016-01-27

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 1 (11)  ·  Diabetes Mellitus, Type 2 (11)  ·  Hyperglycemia (10)  ·  Diabetes Mellitus (8)  ·  Insulin Resistance (4)  ·  Fasting (2)  ·  Adrenocorticotropic hormone deficiency (1)  ·  Autoimmune Diseases (1)  ·  Congenital Hyperinsulinism (1)  ·  Critical Illness (1)  ·  Diabetic Ketoacidosis (1)  ·  Dumping Syndrome (1)  ·  Endocrine System Diseases (1)  ·  Food Preferences (1)

Broader conditions

Nutritional and Metabolic Diseases (34)  ·  Glucose Metabolism Disorders (33)  ·  Metabolic Diseases (33)  ·  Endocrine System Diseases (22)  ·  Diabetes Mellitus (15)  ·  Immune System Diseases (11)  ·  Autoimmune Diseases (10)  ·  Hyperinsulinism (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Behavior (4)  ·  Feeding Behavior (3)  ·  Pathologic Processes (3)  ·  Body Weight (2)  ·  Digestive System Diseases (2)  ·  Disease Attributes (2)

Interventions

Insulin Glargine (6)  ·  Vildagliptin (6)  ·  Insulin (4)  ·  Insulin Aspart (4)  ·  Metformin (4)  ·  Sitagliptin Phosphate (3)  ·  Liraglutide (2)  ·  empagliflozin (2)  ·  glimepiride (2)  ·  pramlintide (2)  ·  (1-6)-alpha-glucomannan (1)  ·  Acarbose (1)  ·  Canagliflozin (1)  ·  Ciprofloxacin (1)  ·  Connor-Davidson Resilience Scale (1)

Sponsors

Emory University (2)  ·  Hvidovre University Hospital (2)  ·  Lund University (2)  ·  Novartis Pharmaceuticals (2)  ·  Steno Diabetes Center Copenhagen (2)  ·  Bassett Healthcare (1)  ·  Baylor College of Medicine (1)  ·  Beni-Suef University (1)  ·  Brigham and Women's Hospital (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Gulhane School of Medicine (1)  ·  Hospital Universitario Clinica San Rafael (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Joslin Diabetes Center (1)

Countries

Denmark (7)  ·  United States (7)  ·  United Kingdom (3)  ·  Egypt (2)  ·  Jordan (2)  ·  Spain (2)  ·  Sweden (2)  ·  Tunisia (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Israel (1)

Top investigators

Ahmed A Elberry, professor (1)  ·  Ajenthen G Ranjan, MD, PhD (1)  ·  Ajenthen Ranjan, MD (1)  ·  Ayman A. Zayed, MD (1)  ·  Caroline C Gormsen, M.D. (1)  ·  Colin McArthur, MBBS (1)  ·  Dalit Modan, M.D. (1)  ·  Dario Giugliano, MD,PhD (1)  ·  Deborah Cook, MBBS (1)  ·  Francisco J Gomez-Perez, MD (1)  ·  Gail Adler, MD/PhD (1)  ·  Guillermo E Umpierrez, MD, CDE (1)

Results publications

PMID 37526194, PMID 11889147, PMID 15793249, PMID 17513708, PMID 19158048, PMID 19190104, PMID 19318384, PMID 19719706, PMID 21228246, PMID 21697252, PMID 22223765, PMID 22727048, PMID 22855332, PMID 22992074, PMID 22996038, PMID 23435159, PMID 24794703, PMID 24920915, PMID 25838513, PMID 26537183, PMID 26656289, PMID 27068361, PMID 27326862, PMID 27797928, PMID 30207748, PMID 30679302, PMID 31337371, PMID 31907828, PMID 34305809, PMID 35467938, PMID 35675498, PMID 36123073, PMID 37093196, PMID 37435938, PMID 37671755, PMID 37853343, PMID 8422838

NIH funding

2019 (1), 2025 (1), K24HL103845 (1), R01HL109634 (1), UL1TR001102 (1)